TrialClinical and translational science2025

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling of Serum M-Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma.

Cheryl Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.